Amy Mahery
Fortune : 6 $ au 31/08/2026
Fortune : 6 $ au 31/08/2026
Amy Mahery is currently an Independent Director at CNS Pharmaceuticals, Inc. since 2024.
Formerly, Ms. Mahery was Chief Commercial Officer at Roivant Sciences Ltd. from 2022 to 2024 and Senior Vice President at EMD Serono, Inc. from 2021 to 2022.
Ms. Mahery completed undergraduate education at Trinity College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/08/2026 | 1 ( 0% ) | 6 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 18/01/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01/12/2024 |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | 01/07/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Trinity College
Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national